Condition: Endometrial Cancer · Sponsor: ARNAS Civico Di Cristina Benfratelli Hospital
The primary endpoint of the present prospective study is to assess the outcomes in terms of acute toxicity of post-operative stereotactic radiotherapy for endometrial cancer
This description comes directly from the study's public registry record.
FRANCESCO CUCCIA, MD · +393334393336 · francesco.cuccia@arnascivico.it
GIUSEPPE FERRERA, MD · +393471533715 · giuseppe.ferrera@arnascivico.it
Always discuss trial participation with your own doctor first.
| ARNAS Civico Hospital | Palermo, Italy | Not Yet Recruiting |
| ARNAS Civico Hospital | Palermo, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06360653